C00-C97
Conditions
Interventions
Group 1: Intervention group: At the beginning of the study, the intervention group will receive access to the psycho-oncological Untire app and a face-to-face introduction in the study center. Over th
Sponsors
Facharztpraxis Prof. Dr. med Zenner
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age 18 years or older - Formally diagnosed with a malignancy - 90 days after therapy start or later - Experiences fatigue at the moderate or severe level: an average composite score (items 1-9) of =4 on the Brief Fatigue Inventory (BFI) - German fluency and literacy - Access to smartphone and internet
Exclusion criteria
Exclusion criteria: -Inability to provide an informed consent -Average composite score (items 1-9) of 3 or less on the Brief Fatigue Inventory (BFI) -No ability to use a smart phone or a tablet -Not German speaking -Use of Untire in the control group -Patients receiving end of life care -Fatigue is caused by demonstrable medical factors such as dehydration, anemia and kidney malfunction. -Patients with other fatigue syndromes than CRF, such as fibromyalgia and chronic fatigue syndrome (CFS) -Receiving treatment for a psychiatric disorder ***Absolute contraindications -acute illnesses -acute relapses or decompensation in chronic diseases -fever > 38 degrees -severe pain -inadequately adjusted blood pressure in hypertension ***Relative contraindications -anemia < 8 g/dL -Thrombocytopenia and coagulation disorders -bone metastases -Comorbidities such as CHD, pAVK, arterial hypertension, diabetes mellitus, osteoarthritis -administration of cytostatic drugs on the day of sport -mediastinal/cardiac irradiation -flu-like symptoms during immunotherapies -epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cancer-Related fatigue (Brief Fatigue Inventory): Assessed at T0 (baseline), T1 (4 weeks), T2 (8 weeks), T3 (12 weeks). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life (EORTC QLQ-C30), psychological distress (distress thermometer (DT)), depression (HADSD), anxiety (HADSD), adherence and compliance (structured interview), patient sovereignty (structured interview), costs (structured interview). All are assessed at T0 (Baseline), T1 (2 weeks), T2 (6 weeks), T3 (12 weeks). The structured interview was developed by Prof. H.P. Zenner (University of Tübingen) and collects objective data. | — |
Countries
Germany
Contacts
Public ContactHans-Peter Zenner
Facharztpraxis Prof. Dr. med Zenner
Outcome results
None listed